IDEXX Laboratories (IDXX) is a publicly traded Healthcare sector company. As of August 10, 2026, IDXX trades at $586.64 with a market cap of $46.22B and a P/E ratio of 40.97. IDXX moved -0.01% today. Year to date, IDXX is -13.28%; over the trailing twelve months it is -9.75%. Its 52-week range spans $356.14 to $769.98. Analyst consensus is buy with an average price target of $696.00. Rallies surfaces IDXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for IDXX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $586.64 |
| Market Cap | $46.22B |
| P/E Ratio | 40.97 |
| EPS | $14.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $769.98 |
| 52-Week Low | $356.14 |
| Volume | 4 |
| Avg Volume | 0 |
| Revenue (TTM) | $4.55B |
| Net Income | $1.14B |
| Gross Margin | 62.45% |
6 analysts cover IDXX: 0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $696.00.